Please contact Jörn Aldag with any inquiries.


Date Title
Hookipa Appoints Dr. Christoph Lengauer as a Non-Executive Director
Hookipa and Gilead Enter into a Collaboration and License Agreement to Develop Immunotherapies Against HIV and Hepatitis B
Hookipa´s TheraT Replicating Viral Vector Platform published in Immunity
Hookipa Shortlisted for European Mediscience Award 2018
Hookipa Presents New Phase 1 Data for HB-101 at the World Vaccine Congress
Hookipa to present at the Cowen and Co. Conference


Date Title

Bio Europe

Copenhagen, Denmark

BIO International Convention 2018

Boston, USA

4th Annual Immuno-Oncology BD&L and Investment Forum

Chicago, USA

ASCO Annual Meeting

Chicago, USA

BioEquity Europe

Ghent, Belgium

European Congress of Clinical Microbiology and Infectious Diseases

Madrid, Spain

Deutsche Biotechnologietage 2018

Berlin, Germany

Kempen Life Sciences Conference

Amsterdam, The Netherlands

World Vaccine Congress

Washington, USA

BIO-Europe Spring

Amsterdam, The Netherlands

Cowen and Co. Annual Health Care Conference

Boston, USA

LEERINK Partners 7th Annual Global Healthcare Conference

New York, USA

Immuno-Oncology 360°

New York, USA

Biotech and Money World Congress

London, UK

J.P. Morgan 36th Annual Healthcare Conference

San Francisco, USA